Noell

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Noell

Quick Facts

Property Description
Active ingredient Ketoconazole
Form Cream, Shampoo, Tablet, Gel
Pharmacological class Antifungal Agent (Antimycotic)
Common use Combating fungal infections
Origin Synthetic derivative

Defining Noell: A Synthetic Imidazole Antifungal

Noell is a medicinal product defined by its sole active ingredient, Ketoconazole, and is primarily classified as an Antifungal Agent or Antimycotic. This compound is a synthetic derivative belonging to the azole family, specifically recognized as an imidazole derivative. Ketoconazole is an established broad-spectrum antifungal agent, used to target diverse fungi, including yeasts and dermatophytes. This indicates that the medicine is utilized for its ability to manage various fungal conditions.

Forms, Administration, and General Purpose

The general purpose of Noell is to combat the growth and spread of fungi within the body, making it a tool for managing mycotic conditions. Noell is typically available as a single-compound (Monotherapy) product in multiple physical dosage form(s), prominently including specialized topical preparations like Cream and Shampoo, alongside Tablet forms. This specialized presentation highlights its versatility, allowing the medicine to be used either through Topical application, which targets localized, superficial infections of the skin or scalp, or through Oral administration for systemic absorption to address deeper, more widespread mycoses. Ketoconazole is considered an essential medicine, affirming its foundational role in treating fungal infections globally.

Regulatory References

  1. Ketoconazole Topical: MedlinePlus Drug Information

What side effects are possible with Noell?

Possible Side Effects and Safety Information

Noell (Ketoconazole) is associated with an official safety profile that highlights several critical risks, as documented in regulatory information from authorities such as the FDA and EMA.

Category Documented Characteristics
Frequency-Classified Reactions Common reactions (affecting 1% to 10% of users) typically involve Gastrointestinal Disorders (e.g., nausea, vomiting, abdominal pain) and Abnormal Liver Function Tests. Less common reactions include headache and dizziness.
System-Organ Classes The official labeling emphasizes effects on the Hepatobiliary Disorders (liver), Endocrine Disorders (adrenal function), and Cardiac Disorders (heart rhythm) due to specific risks.
Serious Adverse Reactions The most significant risks documented are Severe Hepatotoxicity, including potentially fatal cases or those requiring liver transplantation, and the risk of life-threatening ventricular dysrhythmias (e.g., Torsades de Pointes) when co-administered with certain medications. Adrenocortical Insufficiency and severe Anaphylaxis are also noted.
Population/Duration Notes Use is contraindicated in patients with pre-existing acute or chronic liver disease. The onset of severe liver injury may be delayed, occurring after days or months of therapy.
Safety Restrictions Oral use is formally prohibited in individuals with hepatic impairment or when taking specific drugs that could lead to dangerous heart rhythm changes (QT prolongation).

The regulatory safety structure, which includes the FDA Black Box Warning, strictly defines the limits of use for oral Ketoconazole. This profile establishes that the medicine is generally reserved for serious systemic infections when alternative treatments are not available or tolerated, reflecting the official assessment of its significant hepatotoxicity and interaction risks.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Noell (Ketoconazole) is associated with documented risks to the hepatic, endocrine, and cardiovascular systems, particularly following oral ingestion. The severe systemic risks are not typically expected with the proper use of topical forms (cream, shampoo), which may instead result in localized reactions like erythema or a burning sensation.


Documented Manifestations and Severe Outcomes

Oral overdose may present with clinical signs consistent with acute liver injury, including jaundice, anorexia, vomiting, and pain in the upper abdomen. Additional manifestations include signs of adrenal insufficiency, such as weakness and hypotension (low blood pressure). The regulatory profile documents the potential for severe outcomes, including fatal liver failure and life-threatening ventricular dysrhythmias.


Mandated Emergency Actions

Immediate medical attention or a visit to the nearest hospital emergency room is required for any signs of a severe allergic reaction. A doctor must be contacted right away if symptoms suggestive of liver problems or changes in heart rhythm appear. Regulatory documents confirm that no specific antidote is known, and management consists of supportive and symptomatic measures. Procedures such as the administration of activated charcoal and continuous monitoring of liver function, adrenal function, and the QTc interval (ECG) are officially required in an overdose setting.

Therapeutic Uses of Noell

What Noell Treats: Main Uses and Benefits

Noell (Ketoconazole) is applied across domains where additional symptomatic support is needed in situations involving certain distressing symptoms. Its application is focused on several key therapeutic areas.

For severe internal fungal diseases like Blastomycosis and Histoplasmosis, which are conditions characterized by periods of heightened symptoms, it is relevant when supportive symptom management is appropriate. This contributes to easing the overall symptom load in these serious cases.

The medication is also applied to manage cutaneous fungal infections, helping to address symptom clusters that may become disruptive, such as the persistent itching and excessive scaling of Seborrheic Dermatitis (dandruff), ringworm (Tinea infections), and Cutaneous Candidiasis. This offers symptomatic relief that helps patients cope more steadily and assists with maintaining functional stability, contributing to easing the physical discomfort associated with these irritative states.

“A central therapeutic function is to assist with maintaining functional stability and easing the discomfort of recurring fungal manifestations.”


Quick Fact: Focus on Itching and Scaling Symptoms
Symptom Cluster Focus Persistent pruritus, excessive flaking, and scaling
Condition Categories Seborrheic dermatitis, Tinea infections, systemic mycoses
Patient Benefit Supports maintenance of functional stability and daily comfort

Regulatory References

  1. NIH MedlinePlus overview of Ketoconazole Topical

Eligibility and Restrictions for Use

The eligibility for using Noell (Ketoconazole) is strictly defined by regulatory documents, with significant differences between the oral (tablet) and topical (cream, shampoo) forms.

Oral Tablets

Eligibility Status Official Rule
Contraindicated Patients with acute or chronic liver disease [FDA].
Contraindicated Patients taking certain drugs, including specific QT-prolonging and HMG-CoA reductase inhibitor medications [FDA].
Restricted Use Permitted only for specific severe systemic fungal infections when alternative therapies are unavailable or not tolerated [FDA].
Not Established Safety and effectiveness are not established in children younger than 2 years of age [NIH/NLM].

Topical Forms (Cream, Shampoo)

Eligibility Status Official Rule
Contraindicated Individuals with known hypersensitivity (allergy) to the drug [FDA].
Not Established Safety and effectiveness are not established in children younger than 12 years of age [FDA].

Pregnancy and Lactation

Use of all forms during pregnancy is generally categorized as Pregnancy Category C, permitted only if the potential benefit justifies the potential risk to the fetus. Caution is advised for nursing mothers [FDA].

What should I know about interactions with other medicines?

Noell (levonorgestrel/ethinyl estradiol) is a combined oral contraceptive that may interact with various other medicines and herbal products, potentially reducing its effectiveness in preventing pregnancy or increasing the risk of certain side effects.

Medicines That May Reduce Contraceptive Effectiveness

The efficacy of Noell can be compromised by drugs that increase the metabolism of its hormones, primarily through hepatic enzymes. It is crucial to use a reliable non-hormonal back-up method of contraception during and for a period after stopping treatment with these interacting agents. Notable examples include:

  • Certain Anticonvulsants: Carbamazepine, Phenytoin, Phenobarbital, Primidone, Topiramate, and Oxcarbazepine.
  • Certain Anti-HIV/Hepatitis C drugs: Ritonavir-containing regimens (e.g., Ombitasvir/Paritaprevir/Ritonavir with or without Dasabuvir).
  • Antibiotics: Rifampin and Rifabutin.
  • Other Agents: Bosentan (for pulmonary hypertension) and the herbal supplement St. John's wort.

Medicines Whose Effects May Be Altered by Noell

Noell can also affect the concentration of other drugs in the blood, which may require a dosage adjustment. For instance, Noell may increase the levels of certain benzodiazepines (like Diazepam) and decrease the effectiveness of drugs like Lamotrigine (an anti-seizure medication) and some anticoagulants.

Other Important Interactions

Grapefruit juice may slightly increase the levels of Noell hormones, while smoking tobacco significantly increases the risk of serious cardiovascular events (such as blood clots, heart attack, and stroke), particularly in women over 35.

Mechanism of Action

Targeted Modulation of Neuronal Signals

Noell acts through a dual mechanistic strategy at the cellular level. It functions as a Positive Allosteric Modulator (PAM) at specific sites on inhibitory GABA-A receptors, which intensifies the natural effect of the neurotransmitter GABA on the neuron. Concurrently, the molecule blocks voltage-gated sodium channels, thereby limiting the influx of Na^+ ions necessary for cellular depolarization and signal propagation.

Alteration of Excitation-Inhibition Balance

This molecular interaction results in a mechanistic cascade that shifts the overall balance of neuronal signaling. By strengthening the inhibitory (GABAergic) current and suppressing the excitatory ( Na^+ channel-mediated) current, the drug directly modifies early molecular steps that govern signal transmission. This targeted pathway interference results in a measurable decrease in neuronal excitability, contributing to a net shift in the ratio of inhibition to excitation within the central nervous system.

Dosage and Administration Information

How Noell (Ketoconazole) is Used

Noell is administered through two distinct routes—Oral for systemic use, targeting deep-seated fungal infections, and Topical (cream, shampoo) for localized cutaneous conditions. The usage patterns involve specific schedules for administration.


Standard Dosing and Administration

Feature Usage Parameters
Oral Tablet Dosing The typical starting adult dose is 200 mg taken once daily. For insufficient response, the dose may be increased to 400 mg once daily.
Topical Frequency The cream is generally applied once or twice daily, while the 2% shampoo is typically used twice weekly for an initial treatment course.
Administration Condition The oral tablet must be taken with food to ensure maximum systemic absorption. In cases of low gastric acidity, an acidic beverage is required alongside the dose.
Course Duration Treatment duration varies significantly: systemic therapy often requires a minimum of six months, while topical courses for skin infections may last two to six weeks.

Procedural Context

For the topical shampoo, standard procedures require a necessary procedural step: the product must remain in contact with the affected skin or scalp for 3 to 5 minutes prior to rinsing. The use of the oral tablet is limited to patients at least 2 years of age, where a weight-based dose ranging from 3.3 to 6.6 mg/kg once daily is specified for pediatric treatment. Dosage adjustments for renal or hepatic impairment are not explicitly provided in the prescribing summaries.

Recent Clinical Evidence

Research evidence / Overview of studies for Noell

The clinical understanding of Noell (Ketoconazole) is based on a body of research that includes both Randomized Controlled Trials (RCTs) for topical uses and foundational cohort studies for systemic indications. Research has explored the medicine in different forms (creams, shampoos, tablets) by monitoring how symptoms and fungal presence were measured over specific time intervals.


Evidence for Topical Use in Superficial Fungal Conditions

Research on the topical preparations primarily involves short-term, placebo-controlled, and active-comparator randomized trials. These studies are relevant in trials assessing short-term or episodic symptom patterns in conditions like Seborrheic Dermatitis and Tinea infections.

In studies conducted for seborrheic dermatitis, researchers explored outcomes related to physical discomfort, tracking component scores for signs like scaling (flaking), erythema (redness), and pruritus (itching). Findings described group patterns that contribute to understanding symptom patterns over the initial study period. For Tinea infections, studies examined endpoints related to fungal measurement and the evolution of symptoms. However, findings were sometimes varied when comparing this agent against certain other topical antifungals.


Evidence for Oral Use in Endemic Systemic Fungal Diseases

For serious internal fungal conditions like Blastomycosis and Histoplasmosis, the evidence for the tablet form relies on older, foundational prospective trials and cohort studies. These studies focused on outcomes such as clinical success rates and mycological cure over long treatment durations. This evidence remains limited in the context of newer treatment options, and the results apply only to the specific non-life-threatening populations studied.


Key Uncertainties and Research Gaps

Research exploring the long-term outcomes related to Noell is not fully established. For all forms, long-term effects are not fully established regarding the sustained control of symptoms or the prevention of disease recurrence. Comparative evidence is lacking against contemporary first-line systemic antifungals. Furthermore, data for certain groups remain insufficient, with limited information available for very young children or immunocompromised patients.

Key Studies & References

  1. Ketoconazole - LiverTox - NCBI Bookshelf (NIH)

Frequently Asked Questions (FAQ)

Common questions about Noell (FAQ)


Q: Is Noell considered a new drug, or has it been around for a while?

Noell (Ketoconazole) is a medicine that has been used for many years. It is classified as a synthetic antifungal agent. The World Health Organization (WHO) has listed its active ingredient as an essential medicine, highlighting its established role in the treatment of fungal infections globally.


Q: How is Noell different from other common medicines used for the same condition?

Noell belongs to the azole class of antifungal agents. Official research summaries state that current evidence comparing it to other contemporary systemic antifungal treatments is limited. It is defined by its specific chemical structure, which makes it an imidazole derivative.


Q: What is the expected duration of Noell's action after a single use?

Regulatory documents describe that the active ingredient in the oral tablet is cleared from the bloodstream in two main phases. Official information reports that the elimination of the active ingredient from the plasma includes a phase with a mean half-life of approximately 8 hours.


Q: Can Noell be used by adults of all ages?

Official information restricts the use of the oral tablet to individuals aged 2 years and older. While approved for adults, regulatory labeling indicates that the use in older adults is a special consideration that may require attention.


Q: What types of over-the-counter medications should be discussed before using Noell?

The oral tablet needs a certain level of stomach acid to be properly absorbed into the body. Therefore, over-the-counter medicines that reduce stomach acid, such as antacids or those for heartburn, may lessen the effect of Noell. Regulatory guidelines describe that the dose of Noell should be separated from these other medicines by at least two hours to support proper absorption.


Q: Is Noell known to interact with alcohol?

Yes, official warnings mention that consuming alcoholic beverages while using Noell may increase the risk of serious liver problems. Additionally, some rare reactions that resemble a severe reaction to alcohol (flushing, headache, nausea) have been reported when the drug is taken concurrently with alcohol.


Q: Can Noell affect the effectiveness of birth control pills?

Noell can influence the body's metabolism of certain other medicines, including the hormones (estrogen and progestin) found in some oral contraceptive medications. As a result, Noell can potentially increase the blood levels of these hormones.


Q: Is it okay to drive or operate machinery while using Noell?

Because some central nervous system effects are reported, official documents suggest that individuals should understand how the medicine affects them before driving or operating complex machinery. These effects can include dizziness and somnolence (sleepiness).


Q: What happens if a dose is missed?

Official consumer information for the oral tablet describes the proper procedure for a missed dose: if it is almost time for the next scheduled dose, the missed dose is to be skipped to avoid using two doses too closely together.


Q: Are there different forms of Noell (e.g., tablet, liquid, injection)?

Noell is officially available in several preparations, including the oral tablet, cream, shampoo, and gel for topical application. Standard U.S. regulatory information does not list the availability of liquid or injectable forms of this medicine.


Q: Do studies suggest Noell works better for certain subgroups of people?

Regulatory summaries indicate that while studies have generally explored outcomes in broad populations, there are gaps in the research. Specifically, data remains insufficient to establish clear conclusions regarding the drug's use in certain groups, such as very young children or patients with compromised immune systems.


Q: What is the official statement on using Noell during pregnancy?

Official labeling for Noell places it into Pregnancy Category C. This classification means that the drug should only be used during pregnancy if the potential benefits are judged to outweigh any possible risks to the developing fetus.


Q: What is the official information regarding Noell use while breastfeeding?

Official information advises caution for nursing mothers. While data indicates the active ingredient does pass into human milk, the potential effects of this exposure on a nursing infant are not fully known.


Q: Does Noell affect mood or mental health in any documented way?

Regulatory documents list central nervous system effects, including dizziness, confusion, and nervousness. Rare reports of more severe psychiatric adverse reactions, such as suicidal tendencies, have also been noted in official product information.


Q: How long does Noell stay in the system after the last use?

The elimination of the oral tablet from the body follows a two-part pattern, with an initial rapid clearance and a second, slower clearance phase. The medicine is cleared from the system over a period consistent with its reported 2-hour and 8-hour mean half-lives.


Q: What should I know about stopping the use of Noell?

For systemic fungal infections, official information notes that the treatment course may need to be followed for a minimum of six months to prevent the return of the infection. Official prescribing information states that treatment should only be stopped under the guidance of a healthcare professional.


Q: Can Noell be used with herbal supplements or vitamins?

Official safety documents recommend discussion with a healthcare professional regarding all herbal supplements and vitamins due to the potential for interactions. The label specifically notes that the herbal supplement St. John’s wort may reduce the effectiveness of the hormones in combined oral contraceptives.


Q: Is Noell available as a generic medication?

Yes, Noell is the brand name for the medicine whose active ingredient is Ketoconazole. Generic versions containing the same active ingredient are also available to consumers.


Q: Are there specific laboratory tests recommended before or during Noell treatment?

Due to the documented risk of severe liver injury and potential adrenal gland issues, official labeling includes recommendations for assessing and monitoring patients. These assessments typically involve specific laboratory tests to check liver function and adrenal function both before and throughout the course of treatment.


Q: What happens if Noell is used for a longer time than initially intended?

Official documents highlight that serious liver damage has occurred following both short- and long-term use. Additionally, prolonged oral therapy carries an increased risk of developing adrenocortical insufficiency, particularly during periods of increased physical stress.


Q: Can Noell be used by people who have allergies to other medications?

Official eligibility information only addresses contraindication due to a known hypersensitivity (allergy) to Noell itself. Regulatory sources do not provide general guidance on its use for patients with documented allergies to other, unrelated medications.


Q: Does Noell carry any warning about its use in the elderly?

Regulatory documents include a dedicated section on the use of Noell in geriatric patients. This section specifies that, while use is permitted, the elderly population may require special attention regarding dosing or caution due to potential differences in how the body processes the drug.


Q: Can Noell be used by people with diabetes?

Diabetes itself is not listed as a contraindication for Noell. However, regulatory documents list hypoglycemia (low blood sugar) as a possible adverse reaction, which suggests a relevance to patients who need to manage their blood sugar levels.


Q: Does Noell affect blood pressure?

Adrenal insufficiency is a serious risk associated with the oral use of Noell. This condition may present with hypotension (low blood pressure) due to the medicine's potential impact on the body's regulation of water and salts. This is a documented link in official safety information.


Q: What is the information on Noell and eye problems or vision changes?

Official adverse event reports include rare cases of reversible increased intracranial pressure. This condition can potentially cause symptoms such as vision changes or swelling of the optic nerve, as documented in postmarketing reports.


Q: How reliable is the evidence supporting the claims about Noell?

Official research summaries describe the evidence base as consisting of short-term, randomized controlled trials for topical uses and older, foundational cohort studies for systemic indications. However, these same summaries also note research gaps regarding long-term outcomes for all forms of the drug.


Q: What should be done if an allergic reaction to Noell is suspected?

Official safety information regarding suspected severe allergic reactions, such as anaphylaxis (a potentially life-threatening reaction), directs that emergency medical attention must be sought immediately if symptoms like rash, swelling, or difficulty breathing occur.


Q: What is the difference between a contraindication and a precaution for Noell?

In regulatory terms, a contraindication is an absolute restriction, meaning the medicine must not be used because the risks are considered too high for any potential benefit. A precaution describes situations where the drug can be used, but specific caution, monitoring, or risk-management steps are required.


Q: Do official sources list any long-term side effects of Noell?

Yes, official documents describe that the long-term use of the oral tablet is associated with known risks. These risks include the potential for a delayed onset of severe liver injury and the development of adrenocortical insufficiency.


Q: Can Noell be used by people with kidney problems?

Regulatory studies found that the way the body processes Noell was not significantly different in people with renal (kidney) impairment compared to healthy subjects. However, the official prescribing summaries do not provide explicit dosage adjustments for kidney problems.


How should Noell be stored and disposed of?

Storage and Protection Requirements

Noell (Ketoconazole) must be stored at Controlled Room Temperature, generally defined by regulatory labeling as 20 C to 25 C (68 F to 77 F), with permitted excursions to 15 C to 30 C.

  • Tablets must be kept in a tight, light-resistant container and protected from moisture.
  • Topical formulations, such as the shampoo and foam, must be protected from light, and the foam container should not be exposed to heat above 49 C (120 F) or incinerated.
  • It is a mandatory safety instruction to keep all forms of this medication out of the sight and reach of children.
  • Specific formulations carry prohibitions, such as the cream, which must not be frozen.

Disposal Instructions

Unused or expired Noell must be discarded in accordance with local, regional, and national regulations. To protect the environment, the product should not be allowed to enter the sewer system, surface water, or ground water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Noell found in:

A-Z Index: